Search results
Results from the WOW.Com Content Network
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. [7] It is administered via subcutaneous injection to help control the blood sugar level of those with diabetes .
An injector pen consists of a chamber or cartridge of medication, a tip to attach a needle, and a piston or plunger to inject the dose. [4] Some pens, including most insulin pens, include dials to adjust the dose of the injection before each administration. [2]
Insulin is usually taken as subcutaneous injections by single-use syringes with needles, an insulin pump, or by repeated-use insulin pens with needles. People who wish to reduce repeated skin puncture of insulin injections often use an injection port in conjunction with syringes.
It is given as an injection under the skin in the abdominal wall (at the front of the waist), upper arm or thigh. [6] The most frequently reported side effect is hypoglycemia (low blood glucose levels). [6] It was approved for medical use in the European Union in January 2013, [6] and in Australia in November 2017. [2]
This initiative facilitates Novartis AG's use of the Credence technology in injectable medications. Europe is estimated to exhibit a CAGR of 7.28% over the forecast period. The drug delivery devices market in Germany is predicted to expand due to factors like the surging prevalence of chronic diseases, product launches, and the expansion of ...
This is an ultralong-acting insulin analogue developed by Novo Nordisk, which markets it under the brand name Tresiba. It is administered once daily and has a duration of action that lasts up to 40 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir).
Disposable autoinjectors commonly use a pre-loaded spring as a power source. This spring and the associated mechanical components form a one-shot linear actuator. [citation needed] When triggered the actuator drives a three-step sequence: [citation needed] accelerate the syringe forward, puncturing the injection site
Insulin is usually given subcutaneously, either by injections or by an insulin pump.In acute care settings, insulin may also be given intravenously. Insulins are typically characterized by the rate at which they are metabolized by the body, yielding different peak times and durations of action. [4]